CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home›
Investors›
AMR Action Fund›
Library
AMR Action Fund logo

AMR Action Fund

AMR Action Fund focuses on investing in biotechnology companies that are developing treatments for life-threatening antimicrobial-resistant infections. Their investment strategy includes participating in Series B, Series C, and Series E funding rounds, with the goal of launching two to four new antimicrobials over the next decade. The fund also emphasizes creating a sustainable investment environment for these critical pathogen therapies.

2020
Fund
Compare
Portfolio
Employees
Library

AMR Action Fund - Library

amractionfund.com·Crawled Oct 14, 2026·

Topics

Publication type

Content origin
Row density

Blog

6 pages
  1. A timely reality check on silent pandemic of antimicrobial resistance/blog/a-timely-reality-check-on-silent-pandemic-of-antimicrobial-resistance

    A joint statement with IFPMA and the AMR Industry Alliance on new findings about the global AMR burden.

  2. Blog/blog

    AMR Action Fund

  3. CIDRAP: Updated PASTEUR Act reintroduced in Congress/blog/cidrap-updated-pasteur-act-reintroduced-in-congress

    A news article about the re-introduction of the PASTEUR Act in the US Congress.

  4. Efforts to Revive Antibiotic Development With PASTEUR Act, Education, Awareness/blog/efforts-to-revive-antibiotic-development-with-pasteur-act-education-awareness

    A discussion with AMR Action Fund Henry Skinner about the PASTEUR Act

Team

1 page
  1. Team/team

    The company is powered by a group.

About

1 page
  1. About/about

    The AMR Action Fund aims to bring 2-4 new antibiotics to patients by 2030, by enabling sustainable investment in the antibiotic pipeline.

Homepage

1 page
  1. Homepage/

    Aiming to overcome technical and funding barriers in antibiotic development and ensuring a sustainable pipeline of new antibiotics to fight superbugs.

Privacy

1 page
  1. Privacy Policy/privacy-policy

    The AMR Action Fund website is operated by the general partner of the AMR Action Fund. Its terms of use include copyright notices, a privacy statement, and a cookie policy.